SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stuart J. Wong, MD
RTOG Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Centre Hospitalier de L'Université de Montréal
Montreal, Quebec, Canada
- Mcgill University
Montreal, Quebec, Canada
- University of Arizona Cancer Center - North Campus
Tucson, Arizona, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Cleveland Clinic - Weston
Weston, Florida, United States
- University of Louisville, James Graham Brown Cancer Center
Louisville, Kentucky, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Washington University St. Louis
St Louis, Missouri, United States
- Northwell Health
Lake Success, New York, United States
- University of Cincinnati Cancer Center - Uc Medical Center
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center Shadyside
Pittsburgh, Pennsylvania, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Nov 2018
- Primary completion
- 31 Jul 2027
- Completion
- 31 Jul 2029
- Last update posted
- 20 Jan 2026
- Registered enrollment
- 86
- Registry id
- NCT03546582
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.